Atlas Trials

Fuzheng Huayu Tablets for Metabolic Dysfunction-Associated Fatty Liver Cirrhosis (Compensated): A Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Study

Clinical trial NCT07663643 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07663643
Sponsor
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Status
NOT_YET_RECRUITING
Phase
Phase 4
Study type
INTERVENTIONAL
Metabolic Dysfunction-associated Fatty Liver Cirrhosis
Start date
2026-05-25
Primary completion
2027-10-15
Enrollment
459

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.